Search
-
MSK News
Descubra cómo MSK ayuda a las personas que se enfrentan al cáncer en todo lo que necesitan, y comprende la importancia de hablar con los pacientes en el idioma que les brinda tranquilidad.
… Tuesday, November 7, 2023 La llamada telefónica fue alarmante. Beatriz Galvan no esperaba tener noticias de su médico un domingo. Esta abuela de 62 años de Bayville, Long Island, acababa de someterse a un chequeo largamente postergado y a su primera mamografía para la detección del cáncer de mama . Su
-
News
A team at MSK uncovered how TRX518, a new immunotherapy drug in early development, works in the body.
… Tuesday, April 4, 2017 Summary TRX518 enhances the activation of the immune system by targeting a specific receptor on T cells. The findings open up avenues of further study to understand the impact on clinical outcomes. Highlights MSK researchers presented data on TRX518, a type of drug called a monoclonal
-
News
Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of its new Teen and Young Adult (TYA) Program, TYA @ MSK, which will offer special services to MSK’s TYA population. In tandem, MSK officially opened The Lounge, a space designed especially for this unique age group that was made possible by a $1 million donation from Teen Cancer America. The nonprofit organization, co-founded by Roger Daltrey and Pete Townshend of The Who, partners with hospitals throughout the United States to develop specialized facilities for teens and young adults with cancer.
… Friday, March 18, 2016 Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of its new Teen and Young Adult (TYA) Program , TYA @ MSK, which will offer special services to MSK’s TYA population. In tandem, MSK officially opened The Lounge, a space designed especially for this unique
-
News
According to Memorial Sloan Kettering scientists, it has to do with what the virus does to a cell’s DNA repair machinery.
… Thursday, January 30, 2020 Summary Scientists at Memorial Sloan Kettering discovered a possible reason why people with HPV-caused cancers have higher cure rates than people with cancers not caused by the virus. Human papillomavirus (HPV) causes several types of cancer, including cervical , anal , and
-
News
Charles L. Sawyers, MD, Investigator, Howard Hughes Medical Institute (HHMI); Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM) Council, the Academy’s governing and oversight body, for a three-year term.
… Friday, June 7, 2024 Charles L. Sawyers, MD , Investigator, Howard Hughes Medical Institute (HHMI); Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Chair, Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National
-
News
Scientists from Memorial Sloan Kettering Cancer Center and Eureka Therapeutics have collaborated to create the new human monoclonal antibody, which targets a protein associated with many types of cancer and is of great interest to cancer researchers.
… Wednesday, March 13, 2013 Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells. Scientists from Memorial
-
News
Searching for cancer information online has benefits and drawbacks. Here are some tips on how to Google like a pro.
… Tuesday, February 16, 2016 Summary People with cancer often look to the Internet for information. But they especially need to be aware that information they find online about their disease may be inaccurate, misleading, old, or just plain confusing. MSK health education specialists and expert clinicians
-
MSK News
Marie-Josée and Henry R. Kravis have already revolutionized cancer research. Now they are doing it again, by supporting the exploration of the complex ecosystem that permits cancer to thrive — or not — in the body.
… Friday, April 1, 2022 Marie-Josée and Henry R. Kravis have already revolutionized cancer research. Now with a transformational gift of $100 million to establish The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project at Memorial Sloan Kettering Cancer Center (MSK) , they are committed to advancing
-
News
MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.
… Thursday, May 20, 2021 MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track. A joint statement
-
News
Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center investigators.
… Wednesday, August 21, 2013 Patients with advanced kidney cancer can now take advantage of a new treatment option that has far fewer troubling side effects – this, according to a large, international trial led by Memorial Sloan Kettering Cancer Center (MSKCC) investigators. Published in the August 22